Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-21

FDA Approved: MESALAMINE RECTAL — Original Application (Amring Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Amring Pharmaceuticals' Mesalamine Rectal as an Original Application (ANDA 208362), authorizing a generic mesalamine rectal product for ulcerative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine Rectal (Mesalamine)

Snippet

ORIG AP for MESALAMINE RECTAL (MESALAMINE)